Literature DB >> 14605984

Five years and 4 months of recurrence-free survival in hepatic angiosarcoma.

Ilgin Ozden1, Orhan Bilge, Mert Erkan, Uğur Cevikbaş, Koray Acarli.   

Abstract

A 54-year-old woman was referred with the diagnosis of hepatic angiosarcoma, made by percutaneous biopsy under ultrasonographic guidance. Ultrasonography (US) had revealed a 48 x 42 x 35 mm mass in the right lobe. Standard biochemical tests and whole blood count had yielded normal results. At our institution, magnetic resonance imaging demonstrated a hypervascular mass in the right lobe. Alpha-fetoprotein, carcinoembryonic antigen, and carbohydrate antigen 19-9 levels were normal. Serological tests were negative for hepatitis B and C viruses. There was no evidence of metastasis. A right hepatectomy was performed. Histopathological examination confirmed the diagnosis of angiosarcoma. However, there was a suspicion of microscopically positive margins. Relaparotomy and resection of a 1-cm-thick slice of hepatic parenchyma was performed. Histopathological examination revealed necrotic tumor cells at the previous margin. The new surgical margin was tumor free. Due to the expected poor prognosis, prophylactic chemoembolization of the remnant liver (lipiodol + adriamycin + mitomycin) was performed at 3 and 7 months postoperatively. She has been alive without recurrence for 5 years and 4 months. Hepatic angiosarcoma has two distinct presentations: multiple tumors and a solitary tumor. The reported poor results largely stem from the predominance of the multiple tumors and consequent unresectability. Long-term survival is possible in solitary resectable hepatic angiosarcomas.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14605984     DOI: 10.1007/s00534-003-0849-4

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  12 in total

1.  Hepatic angiosarcoma five years following spontaneous intraperitoneal bleed of a hepatic mass.

Authors:  Jessica L Cioffi-Pretti; Alexandra N Kalof; George Ebert; Laurence E McCahill
Journal:  Rare Tumors       Date:  2009-12-28

2.  Statistics and outlook of primary hepatic angiosarcoma based on clinical stage.

Authors:  I-Hsuan Huang; Yi-Ying Wu; Tzu-Chuan Huang; Wei-Kuo Chang; Jia-Hong Chen
Journal:  Oncol Lett       Date:  2016-03-17       Impact factor: 2.967

Review 3.  Ruptured angiosarcoma of the liver treated by emergency catheter-directed embolization.

Authors:  Christine Leowardi; Yura Hormann; Ulf Hinz; Moritz N Wente; Peter Hallscheidt; Christa Flechtenmacher; Markus W Buchler; Helmut Friess; Matthias H M Schwarzbach
Journal:  World J Gastroenterol       Date:  2006-02-07       Impact factor: 5.742

4.  Molecular cytogenetic characterization of undifferentiated embryonal sarcoma of the liver: a case report and literature review.

Authors:  Xiaoxia Hu; Haiying Chen; Meishan Jin; Xianfu Wang; Jiyun Lee; Weihong Xu; Rui Zhang; Shibo Li; Junqi Niu
Journal:  Mol Cytogenet       Date:  2012-05-03       Impact factor: 2.009

5.  Haemorrhaging lesion in the breast: is there a role for embolisation?

Authors:  Na Taib; Ch Yip; S Ranganathan; F Moosa; Ks Mun
Journal:  Biomed Imaging Interv J       Date:  2006-07-01

6.  Hepatic angiosarcoma may have fair survival nowadays.

Authors:  Neng-Chyan Huang; Yau-Chang Kuo; Jui-Chin Chiang; Shih-Yuan Hung; Huay-Min Wang; Yao-Min Hung; Yun-Te Chang; Shue-Ren Wann; Hong-Tai Chang; Jyh-Seng Wang; Sheng-Yow Ho; How-Ran Guo
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

7.  Cancer registry study of malignant hepatic vascular tumors: hepatic angiosarcomas and hepatic epithelioid hemangioendotheliomas.

Authors:  Constanza Martínez; Jonathan K Lai; Daryl Ramai; Antonio Facciorusso; Zu-Hua Gao
Journal:  Cancer Med       Date:  2021-12-01       Impact factor: 4.452

8.  Hepatic angiosarcoma presenting as an acute intraabdominal hemorrhage treated with transarterial chemoembolization.

Authors:  Glenn William Stambo; Michael J Guiney
Journal:  Sarcoma       Date:  2007

9.  Contrast uptake in primary hepatic angiosarcoma on gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in the hepatobiliary phase.

Authors:  Manabu Hayashi; Satoshi Kawana; Hirofumi Sekino; Kazumichi Abe; Naoki Matsuoka; Masahito Kashiwagi; Ken Okai; Yukiko Kanno; Atsushi Takahashi; Hiroshi Ito; Yuko Hashimoto; Hiromasa Ohira
Journal:  World J Hepatol       Date:  2018-01-27

10.  Clinical characteristics of primary hepatic angiosarcoma outcomes: a SEER database analysis.

Authors:  Dong Zeng; Xianghua Zeng; Jun Duan; Diangang Chen; Bo Zhu
Journal:  Transl Cancer Res       Date:  2021-01       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.